UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 8-K

                      Current Report Pursuant o Section 13
                or 15 (d) of the Securities Exchange Act of 1934


Date of report (Date of earliest event reported):  January 10, 2005
                                                   (January 4, 2005)

                        Bio Solutions Manufacturing, Inc.
- --------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

    New York                        000-33229                   16-1576984
- ----------------------        ------------------------     ---------------------
(State or Other Jurisdiction  (Commission File Number)     (I.R.S. Employer
  of Incorporation)                                          Identification No.)


                    1161 James Street, Hattiesburg, MS 39401
                   ------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)

Registrant's Telephone Number, Including Area Code: (601) 582-4000


                                      N/A
                   ------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425

[_]  Soliciting  material  pursuant to Rule 14a-12  under the  Exchange  Act (17
     CFR240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange
     Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement  communications  pursuant  to Rule  13(e)-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))






SECTION 1- REGISTRANT'S BUSINESS AND OPERATIONS

     Not Applicable


SECTION 2 - FINANCIAL INFORMATION

     Not Applicable


SECTION 3 - SECURITIES AND TRADING MARKETS

     Not Applicable


SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL INFORMATION

     Not Applicable


SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT

Item 5.02 Departure of Director

     On January 4, 2005, the Company received  notice,  dated December 30, 2004,
of and  thereby  subsequently  accepted  the  resignation  of Joe H. Ashley as a
Director.


SECTION 6 - [Reserved]

     Not Applicable


SECTION 7 - REGULATION FD

     Not Applicable



                                   Page 2 of 3





SECTION 8 - OTHER EVENTS

     Not Applicable


SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01 Finanical Statements and Exhibits

     (c) Exhibits.

Exhibit No.    Description
- -----------------------------------------

17.1  *        Resignation of Director.

- ------------------
* Filed herewith.




                                   SIGNATURES



     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                    Bio Solutions Manufacturing, Inc..


Date:   January 10, 2005            By:     /s/ Krish V. Reddy
- ------------------------------       ---------------------------------------
                                    Krish V. Reddy, Ph.D.,
                                    President








                                   Page 3 of 2